{"id":780976,"date":"2023-08-30T10:28:46","date_gmt":"2023-08-30T14:28:46","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-september-conferences\/"},"modified":"2023-08-30T10:28:46","modified_gmt":"2023-08-30T14:28:46","slug":"clene-to-present-at-upcoming-september-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-september-conferences\/","title":{"rendered":"Clene to Present at Upcoming September Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SALT LAKE CITY, Aug.  30, 2023  (GLOBE NEWSWIRE) &#8212; Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, \u201cClene\u201d) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson\u2019s disease, and multiple sclerosis, today announced that it will participate in the following investor conferences in September.<\/p>\n<p>\n        <strong>H.C. Wainwright 25<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Global Investment Conference<\/strong><br \/>\n        <br \/>Date: September 11-13, 2023<br \/>Location: Lotte New York Palace Hotel, New York, NY<br \/>Date and Time of Presentation: Available September 11, 2023, at 7:00 a.m. ET<br \/>Format: Corporate Presentation and 1&#215;1 meetings<br \/>Webcast Link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ksgm3Ptax1TLZ5eevGJVvavxTbQ7c9y3TJTJakD82gmn0SnHg5D0nH7mK_lEyJE7HDKh9zD6nRiYK54_bNsYqlkJwWdrRYa9mPajue0-4ONBZr6Ggt88r0rThQcYcI6jJ3Z9SxillyUMNxNJGevSkSr4OojvNL3MqqlnW6Ru1XXERrE-XokHMC5ZyNayI_RZnWeEBEU-8llYdZFE9xp7fQ==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/journey.ct.events\/view\/3eb50cf4-1561-4363-8e78-ac2c56092fb6<\/a><\/p>\n<p>\n        <strong>Cantor Fitzgerald Annual Global Healthcare Conference<\/strong><br \/>\n        <br \/>Dates: September 26-28, 2023<br \/>Location: InterContinental Barclay Hotel, New York, NY<br \/>Date and Time of Panel Presentation: September 26, 2023, at 11:35 a.m. ET<br \/>Format: Panel Presentation and 1&#215;1 meetings<\/p>\n<p>A webcast of the presentations, if available, will be available on the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IEx72E5e09_g8EWVyZaSfySaT6tTHpKg2ZT7UyBGrOB4LS-cDzb1h_w0rYOEcRY34LXy5Zvd9OyHo1TbCUHJG_282ASMBXdbHrOPBdaIRyA=\" rel=\"nofollow noopener\" target=\"_blank\">Events<\/a>\u201d section of the Clene website.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>About Clene<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, \u201cClene\u201d) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson\u2019s disease, and multiple sclerosis. CNM-Au8<sup>\u00ae<\/sup> is a federally registered trademark of Clene Nanomedicine, Inc. The company is based in Salt Lake City, Utah, with R&amp;D and manufacturing operations in Maryland. For more information, please visit www.clene.com or follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7r-aYgXOerIWqZ0rNtxOUUEfL3y-9LOuksdfv-WECPWsKFJeRJsi00H_4xO9GNvGGqqUYDV1Fnb03p_7F27K_w==\" rel=\"nofollow noopener\" target=\"_blank\">Twitter<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kgXEdxsgTdZ_Yb8mDbNP5m2t1FqKmm1FYiphb3kXYNOX_KnhuVCNwW78mvoOwvd9Qvaf5SoNnFXItEWYZKFfcfYdKwMc_aUnK27-cX23EEVZ3NaqnJrvGV9lr0DG6WXD\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QJErLcMpkeKUcbrxeNzhhOwckdSR1d9nAGcgBQMsgVMXgUSjKF-A1qRpMJfWOL44vztMlJmIE3nhplr3_YfFP7D7bTK_A-5YO1mLfvT6TYY=\" rel=\"nofollow noopener\" target=\"_blank\">Facebook.<\/a><\/p>\n<p align=\"justify\">\n        <strong>Contacts:<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:50%;width:50%;min-width:50%;vertical-align: bottom\">\n            <strong><br \/>\n              <u>Media Contact<\/u><br \/>\n            <\/strong>\n          <\/td>\n<td style=\"max-width:50%;width:50%;min-width:50%;vertical-align: bottom\">\n            <strong><br \/>\n              <u>Investor Contact<\/u><br \/>\n            <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">Ignacio Guerrero-Ros, Ph.D., or David Schull<\/td>\n<td style=\"vertical-align: bottom\">Kevin Gardner<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">Russo Partners, LLC<\/td>\n<td style=\"vertical-align: bottom\">LifeSci Advisors<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">\n            <a href=\"mailto:Ignacio.guerrero-ros@russopartnersllc.com\" rel=\"nofollow noopener\" target=\"_blank\">Ignacio.guerrero-ros@russopartnersllc.com<\/a>\n          <\/td>\n<td style=\"vertical-align: bottom\">\n            <a href=\"mailto:kgardner@lifesciadvisors.com\" rel=\"nofollow noopener\" target=\"_blank\">kgardner@lifesciadvisors.com<\/a>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">\n            <a href=\"mailto:David.schull@russopartnersllc.com\" rel=\"nofollow noopener\" target=\"_blank\">David.schull@russopartnersllc.com<\/a>\n          <\/td>\n<td style=\"vertical-align: bottom\">617-283-2856<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">\u00a0<\/td>\n<td style=\"vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzEyMiM1Nzg5MTczIzIyNDY0NDY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZWY2OGZlODEtNWMzYi00NDA5LThhMmMtMjlkNmUzZmQ4MGU4LTEyNTc5OTk=\/tiny\/Clene-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SALT LAKE CITY, Aug. 30, 2023 (GLOBE NEWSWIRE) &#8212; Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, \u201cClene\u201d) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson\u2019s disease, and multiple sclerosis, today announced that it will participate in the following investor conferences in September. H.C. Wainwright 25 th Annual Global Investment Conference Date: September 11-13, 2023Location: Lotte New York Palace Hotel, New York, NYDate and Time of Presentation: Available September 11, 2023, at 7:00 a.m. ETFormat: Corporate Presentation and 1&#215;1 meetingsWebcast Link: https:\/\/journey.ct.events\/view\/3eb50cf4-1561-4363-8e78-ac2c56092fb6 Cantor Fitzgerald Annual Global Healthcare Conference Dates: September 26-28, 2023Location: InterContinental Barclay Hotel, New York, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-september-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Clene to Present at Upcoming September Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-780976","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Clene to Present at Upcoming September Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-september-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clene to Present at Upcoming September Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SALT LAKE CITY, Aug. 30, 2023 (GLOBE NEWSWIRE) &#8212; Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, \u201cClene\u201d) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson\u2019s disease, and multiple sclerosis, today announced that it will participate in the following investor conferences in September. H.C. Wainwright 25 th Annual Global Investment Conference Date: September 11-13, 2023Location: Lotte New York Palace Hotel, New York, NYDate and Time of Presentation: Available September 11, 2023, at 7:00 a.m. ETFormat: Corporate Presentation and 1&#215;1 meetingsWebcast Link: https:\/\/journey.ct.events\/view\/3eb50cf4-1561-4363-8e78-ac2c56092fb6 Cantor Fitzgerald Annual Global Healthcare Conference Dates: September 26-28, 2023Location: InterContinental Barclay Hotel, New York, &hellip; Continue reading &quot;Clene to Present at Upcoming September Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-september-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-30T14:28:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzEyMiM1Nzg5MTczIzIyNDY0NDY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-upcoming-september-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-upcoming-september-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Clene to Present at Upcoming September Conferences\",\"datePublished\":\"2023-08-30T14:28:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-upcoming-september-conferences\\\/\"},\"wordCount\":294,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-upcoming-september-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMzEyMiM1Nzg5MTczIzIyNDY0NDY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-upcoming-september-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-upcoming-september-conferences\\\/\",\"name\":\"Clene to Present at Upcoming September Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-upcoming-september-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-upcoming-september-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMzEyMiM1Nzg5MTczIzIyNDY0NDY=\",\"datePublished\":\"2023-08-30T14:28:46+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-upcoming-september-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-upcoming-september-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-upcoming-september-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMzEyMiM1Nzg5MTczIzIyNDY0NDY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMzEyMiM1Nzg5MTczIzIyNDY0NDY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clene-to-present-at-upcoming-september-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clene to Present at Upcoming September Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clene to Present at Upcoming September Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-september-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Clene to Present at Upcoming September Conferences - Market Newsdesk","og_description":"SALT LAKE CITY, Aug. 30, 2023 (GLOBE NEWSWIRE) &#8212; Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, \u201cClene\u201d) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson\u2019s disease, and multiple sclerosis, today announced that it will participate in the following investor conferences in September. H.C. Wainwright 25 th Annual Global Investment Conference Date: September 11-13, 2023Location: Lotte New York Palace Hotel, New York, NYDate and Time of Presentation: Available September 11, 2023, at 7:00 a.m. ETFormat: Corporate Presentation and 1&#215;1 meetingsWebcast Link: https:\/\/journey.ct.events\/view\/3eb50cf4-1561-4363-8e78-ac2c56092fb6 Cantor Fitzgerald Annual Global Healthcare Conference Dates: September 26-28, 2023Location: InterContinental Barclay Hotel, New York, &hellip; Continue reading \"Clene to Present at Upcoming September Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-september-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2023-08-30T14:28:46+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzEyMiM1Nzg5MTczIzIyNDY0NDY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-september-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-september-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Clene to Present at Upcoming September Conferences","datePublished":"2023-08-30T14:28:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-september-conferences\/"},"wordCount":294,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-september-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzEyMiM1Nzg5MTczIzIyNDY0NDY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-september-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-september-conferences\/","name":"Clene to Present at Upcoming September Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-september-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-september-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzEyMiM1Nzg5MTczIzIyNDY0NDY=","datePublished":"2023-08-30T14:28:46+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-september-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-september-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-september-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzEyMiM1Nzg5MTczIzIyNDY0NDY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzEyMiM1Nzg5MTczIzIyNDY0NDY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clene-to-present-at-upcoming-september-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Clene to Present at Upcoming September Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/780976","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=780976"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/780976\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=780976"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=780976"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=780976"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}